Skip to main navigation
Skip to search
Skip to main content
Sort by
Immunology and Microbiology
Human Immunodeficiency Virus
100%
Herpes Simplex Virus
89%
Herpes Simplex Virus 2
65%
Glycoprotein
64%
Vaccine Efficacy
39%
Monospecific Antibody
37%
Microbicide
37%
Human Alphaherpesvirus 1
34%
Mouse
34%
Viral Disease
32%
Genital Herpes
31%
Mediator
29%
Human Immunodeficiency Virus 1
28%
Escherichia coli
26%
Antibody-Dependent Cell-Mediated Cytotoxicity
24%
Secretion (Process)
24%
Mucosal Immunity
22%
Transplant Procedure
19%
Wild Type
18%
Viral Entry
17%
Cytokine
17%
Fc Receptor
15%
Blood Plasma
14%
Antimicrobial Activity
14%
Vaginal Flora
14%
T-Helper Cell
14%
Human Immunodeficiency Virus Infection
13%
Tenofovir
13%
Defensin
13%
Solid Organ Transplantation
12%
Immunocompetent Cell
12%
Vaginal Microbicide
11%
Virion
11%
Immune Response
11%
Neutralizing Antibody
11%
Drug Megadose
11%
Antibody Response
11%
Immunoglobulin A
10%
Neutrophil
10%
Severe Acute Respiratory Syndrome Coronavirus 2
10%
Wart Virus
10%
Titer
9%
Nonoxynol-9
9%
Cell Surface
9%
interferon
9%
Innate Immune System
9%
Leukocyte
9%
Microbiome
9%
Virus Attachment
9%
COVID-19
9%
Keyphrases
Herpes Simplex Virus
29%
Herpes Simplex Virus 2 (HSV-2)
27%
AIDS/HIV
25%
Cervicovaginal Lavage
21%
Virus
16%
Glycoprotein D
15%
Herpes Simplex Virus Infection
14%
Herpes Simplex Virus Type 1 (HSV-1)
14%
Microbicides
14%
Human Immunodeficiency Virus Type 1 (HIV-1)
14%
Mucosal Immunity
13%
Immune Mediators
13%
Genital Tract
11%
Genital Herpes
11%
HIV Infection
10%
Tenofovir Gel
10%
Female Genital Tract
10%
Pediatric Transplantation
10%
Neural Diseases
10%
Immunization
10%
Vaginal Diseases
10%
Herpes Simplex Type 2
10%
Mucosal Immune Response
9%
Virus Activity
9%
Glycoprotein B
8%
Pre-exposure Prophylaxis (PrEP)
8%
Placebo
8%
HIV Patients
8%
Vaginal Microbiome
8%
Antimicrobial Activity
8%
Solid Organ Transplant Recipients
8%
Glycoprotein C
7%
Escherichia Coli
7%
Tenofovir
7%
Levonorgestrel
7%
Living with
7%
Genital Herpes Simplex Virus
7%
Microbicide Trials
7%
Skin Diseases
7%
Topical Microbicides
7%
Herpes Simplex
7%
HIV Pre-exposure Prophylaxis
7%
Non-neutralizing
7%
Bacterial Vaginosis
7%
Genital Tract Inflammation
7%
Vaginal Ring
7%
CD4+ T Cells
6%
Cervical mucus
6%
COVID-19
6%
Secretory Leukocyte Protease Inhibitor
6%
Medicine and Dentistry
Human Immunodeficiency Virus
42%
Infection
36%
Pediatrics
35%
Herpes Simplex Virus
21%
Transplantation
21%
Herpes Genitalis
19%
Microbicide
18%
Disease
17%
Hormonal Contraception
14%
COVID-19
13%
Cytomegalovirus
13%
Mucosal Immunity
11%
Herpes Simplex
10%
Herpes Simplex Virus 2
10%
Solid Organ Transplantation
9%
Human Immunodeficiency Virus Infection
9%
Pathogen
8%
Virus Infection
8%
Mediator
7%
Prevalence
7%
Severe Acute Respiratory Syndrome Coronavirus 2
7%
Antibiotics
7%
Clinical Trial
7%
Intestine Transplantation
7%
Bacterial Vaginosis
7%
Appendicitis
7%
Contraceptive Agent
6%
Placebo
6%
Immunoglobulin A
6%
Immunocompetent Cell
6%
Genital Tract Infection
6%
Biological Marker
5%
Cohort Effect
5%
Immunosuppressive Treatment
5%
Lavage
5%
Liver Transplantation
5%
Secretion (Process)
5%